| 12264139 |
Aryl sulfonamides as BLT1 antagonists |
Yongxin Han, Satyanarayana Tummanapalli, Phieng Siliphaivanh, Kerrie Spencer |
2025-04-01 |
|
| 12152019 |
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors |
Dane Clausen, Ping Chen, Xavier Fradera, Liangqin Guo, Yongxin Han +5 more |
2024-11-26 |
$487,297,000 |
| 11981701 |
PRMT5 inhibitors |
Michelle R. Machacek, Michael H. Reutershan, Sebastian Schneider |
2024-05-14 |
$214,139,000 |
| 11685761 |
Cyclic di-nucleotide compounds as sting agonists |
Brian M. Andresen, Frank Bennett, Wonsuk Chang, Matthew L. Childers, Jared N. Cumming +3 more |
2023-06-27 |
$825,446,000 |
| 11466047 |
Cyclic di-nucleotide compounds as sting agonists |
Wen-Lian Wu, Jared N. Cumming, Benjamin Wesley Trotter, Wonsuk Chang |
2022-10-11 |
$179,781,000 |
| 11319283 |
Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Meredeth A. McGowan, Abdelghani Achab, Xavier Fradera, Yongxin Han, Derun Li +6 more |
2022-05-03 |
$363,616,000 |
| 11111232 |
Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Catherine White, Abdelghani Achab, Indu T. Bharathan, Xavier Fradera, Yongxin Han +7 more |
2021-09-07 |
$168,031,000 |
| 10793557 |
Sting agonist compounds |
Michael D. Altman, Brandon D. Cash, Matthew L. Childers, Jared N. Cumming, Duane DeMong +7 more |
2020-10-06 |
$187,967,000 |
| 10766919 |
Cyclic di-nucleotide compounds as sting agonists |
Michael D. Altman, Brian M. Andresen, Wonsuk Chang, Matthew L. Childers, Jared N. Cumming +13 more |
2020-09-08 |
$250,625,000 |
| 10759805 |
Compounds that are ERK inhibitors |
Xianhai Huang, Ronald D. Ferguson, Wei Zhou, Christopher W. Boyce, Phieng Siliphaivanh +4 more |
2020-09-01 |
$257,146,000 |
| 10759825 |
Cyclic di-nucleotide compounds as STING agonists |
Michael D. Altman, Brian M. Andresen, Wonsuk Chang, Matthew L. Childers, Jared N. Cumming +7 more |
2020-09-01 |
$257,146,000 |
| 10730849 |
Benzo[b]thiophene compounds as STING agonists |
Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle +9 more |
2020-08-04 |
$369,157,000 |
| 10703738 |
Benzo[b]thiophene compounds as STING agonists |
Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle +9 more |
2020-07-07 |
$367,455,000 |
| 10414747 |
Benzo[b]thiophene compounds as sting agonists |
Michael D. Altman, Brandon D. Cash, Wonsuk Chang, Jared N. Cumming, Andrew M. Haidle +9 more |
2019-09-17 |
$91,414,000 |
| 10336733 |
Aryl acylsulfonamides as BLT1 antagonists |
Yongxin Han, Satyanarayana Tummanapalli, Phieng Siliphaivanh, Kerrie Spencer |
2019-07-02 |
$172,432,000 |
| 10329294 |
Pyrazolopyrimidine inhibitors of IRAK4 activity |
Michael D. Altman, Jason D. Brubaker, Craig R. Gibeau |
2019-06-25 |
$97,538,000 |
| 10329295 |
Pyrrolotriazine inhibitors of IRAK4 activity |
Michael D. Altman, Jason D. Brubaker, Craig R. Gibeau |
2019-06-25 |
$97,538,000 |
| 10155765 |
Carboxamide inhibitors of IRAK4 activity |
Michael D. Altman, Matthew L. Childers, Craig R. Gibeau, Ginny D. Ho, Honchung Tsui |
2018-12-18 |
$82,327,000 |
| 10106574 |
Cyclic di-nucleotide compounds as sting agonists |
Michael D. Altman, Wonsuk Chang, Jared N. Cumming, Rui Liang, Tony Siu +3 more |
2018-10-23 |
$118,425,000 |
| 10065967 |
Compounds that are ERK inhibitors |
Xianhai Huang, Ronald D. Ferguson, Wei Zhou, Christopher W. Boyce, Phieng Siliphaivanh +4 more |
2018-09-04 |
$106,918,000 |
| 10040798 |
Pyrrolopyridazine inhibitors of IRAK4 activity |
Michael D. Altman, Jason D. Brubaker, Craig R. Gibeau |
2018-08-07 |
$151,609,000 |
| 10040802 |
Thienopyrazine inhibitors of IRAK4 activity |
Michael D. Altman, Craig R. Gibeau |
2018-08-07 |
$151,609,000 |
| 9969749 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio +9 more |
2018-05-15 |
$97,235,000 |
| 9943516 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Brian M. Andresen, Jason D. Brubaker, Anthony Donofrio, Thierry O. Fischmann +8 more |
2018-04-17 |
$82,364,000 |
| 9932350 |
Inhibitors of IRAK4 activity |
Michael D. Altman, Jason D. Brubaker, Matthew L. Childers, Anthony Donofrio, Thierry O. Fischmann +8 more |
2018-04-03 |
$81,854,000 |
